Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study

Conclusion.Our analysis showed no differences in miR29b and 199a expression, and differences in baseline CTCs in women with newly diagnosed ovarian tumors were not statistically significant.

Source: The Oncologist - November 12, 2019 Category: Cancer & Oncology Authors: Emil Lou, Rachel I. Vogel, Spencer Hoostal, Phillip Wong, Aaron Grad, Minnu Monu, Tomasz Łukaszewski, Jaai Deshpande, Elizabeth L. Dickson, Molly Klein, Michael A. Linden, Subbaya Subramanian, Deanna Teoh, Melissa A. Geller Tags: Gynecologic Oncology, Chinese Edition, Clinical Trial Results Source Type: research